NASDAQ NMS - GLOBAL MARKET · INM
+2.26% · +$0.0300 · Vol 28.7K
Live · updated 10:46:55 ET
InMed Pharmaceuticals Inc

InMed Pharmaceuticals Inc

Pharmaceuticals
$1.36
Card
Relationship Map

Follow $INM

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $INM by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
INM
InMed Pharmaceuticals Inc
Thu Oct 8 · last completed session · daily score · 16h old
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

37/ 100
Veridion Score
Lower range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4 of 6 factors measured · Thu Oct 8 · last completed session · daily score · 16h old
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is INM moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading INM catalysts
About InMed Pharmaceuticals Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
6
Country
CA

InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment of Alzheimer's, ocular and dermatological indications.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.35
Day high
$1.44
Day low
$1.35
Previous close
$1.33
52W high
$2.35
-42.13% from high
52W low
$0.6150
43% of range
Market cap
$7.3M
EPS
$-2.8807
Beta
-0.08
Shares out
5.5M
Volume
28.7K
0.47× rel vol
Avg volume
60.4K
VWAP
$1.40
Price history computed in-house
1W
+2.26%
1M
+3.82%
3M
-17.07%
1Y
-42.13%
YTD
+28.30%
SMA 50 $1.39 · below
SMA 200 $1.18 · above
52W position 43%

INM overview

Veridion Score
37
Registered · 2026-10-08
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around INM.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading INM Form 4 filings
Public disclosures

Congress activity in INM

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

INM contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INM in this window.
Lobbying spend

INM lobbying filings, year to date.

Registered lobbying filings matched to InMed Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INM in this window.
Loading news for INM
Analyst ratings
Sovereign unlock shows live analyst consensus for INM.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.